Martin O'Malley

Martin O'Malley's policies onHealthcare

Release clinical trial data to advance scientific discovery

Thousands of patients each year volunteer to be part of clinical research, but the results can be hidden from researchers and the public forever. O’Malley will pursue a policy of automatically releasing clinical trial data after the product is approved, and 1 year after the product is rejected (if the product has not been resubmitted). In addition, O’Malley will assure that FDA develops and releases a summary of all major agency decisions. These policies will promote transformative drug development by reducing duplication in science and helping tomorrow’s scientific discoveries learn from today’s successes and failures.

Found an error or want to make a contribution?